The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorder

Background. Co-morbidity may influence GPs' treatment decisions for patients with anxiety. However, knowledge about differences in the pharmacological treatment of anxiety disorders in patients with and without co-morbidity is lacking. Objective. To compare GPs' pharmacological treatment p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Family practice 2007-12, Vol.24 (6), p.538-546
Hauptverfasser:	Smolders, Mirrian, Laurant, Miranda, van Rijswijk, Eric, Mulder, Jan, Braspenning, Jozé, Verhaak, Peter, Wensing, Michel, Grol, Richard
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antidepressant drugs Anxiety Anxiety disorders Anxiety Disorders - drug therapy Benzodiazepines Cohort Studies Cohort study Comorbidity Decision Making Drug Prescriptions - statistics & numerical data family medicine Female General practice Humans Male Medical Records Systems, Computerized Middle Aged Netherlands patient record Physicians, Family Practice Patterns, Physicians prescribing psychiatry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!